Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Validity of an AI-Based Biological Signal Analysis Software Vital-PICASO for Predicting the Risk of Hypoxia Within 24 Hrs Using Vital Sign (SBP, DBP, HR, RR, BT, SpO₂) From General Ward Inpatients; A Retrospective, Single-Center, Single-Arm, Superiority-confirmatory Clinical Trial

NCT07742813 is registered in ClinicalTrials.gov with Huinno AIM as lead sponsor.

NCT NCT07742813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07742813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Validity of an AI-Based Biological Signal Analysis Software Vital-PICASO for Predicting the Risk of Hypoxia Within 24 Hrs Using Vital Sign (SBP, DBP, HR, RR, BT, SpO₂) From General Ward Inpatients; A Retrospective, Single-Center, Single-Arm, Superiority-confirmatory Clinical Trial
Lead sponsor
Huinno AIM
Phase
Observational
Overall status
Completed
Start date
August 20, 2025
Completion date
July 7, 2026
Enrollment
2,250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxia